Skip to content

NAF has launched a petition on Change.org calling on the FDA to prioritize treatment options for rare diseases with urgent unmet needs, including Spinocerebellar Ataxia (SCA)
 SIGN THE PETITION

Celeste Suart

Project Coordinator

Hamilton, Ontario, Canada

Celeste Suart is a PhD student with Dr. Ray Truant’s group at McMaster University, Canada. She obtained her BHSc in Biomedical Discovery and Commercialization from McMaster University. Her current work focuses on characterizing the response of ataxin-1 (the protein affect in SCA1) to DNA damage and reactive oxygen species stress.

Translate »

Join the Ataxia community today!

Become a free member for exclusive content from NAF.